Clinical Trial Update: Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

This update reports results from a Phase 1/2 trial testing Erlotinib and Cetuximab in patients with advanced solid tumors, with emphasis on non-small cell lung …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• Tarceva (erlotinib)

Snippet

Sponsor: University of California, Davis | Conditions: Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-05-08